Journal of the Association of Nurses in AIDS Care
Volume 21, Issue 6 , Pages 478-488 , November 2010

Assessing Medication Adherence of Perinatally HIV-Infected Children Using Caregiver Interviews

References 

  1. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–266
  2. Farley JJ, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. Journal of Acquired Immune Deficiency Syndromes. 2003;33(2):211–218
  3. Freedman D, Koenig LJ, Wiener J, Abrams EJ, Carter RJ, Tepper V, et al Challenges to re-enrolling perinatally HIV-infected and HIV-exposed but uninfected children into a prospective cohort study: Strategies for locating and recruiting hard-to-reach families. Paediatric and Perinatal Epidemiology. 2006;20(4):338–347
  4. Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatric Infectious Disease Journal. 2003;22(1):56–62
  5. Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR, et al Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. New England Journal of Medicine. 2001;345(21):1522–1528
  6. Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, et al Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. Journal of Infectious Diseases. 2005;191(3):339–347
  7. Johnson SB. Chronic disease of childhood: Assessing compliance with complex medical regimens. In:  Krasnegor MA,  Epstein L,  Johnson SB,  Yaffe SJ editor. Developmental aspects of health compliance behavior. Hillsdale: Erlbaum; 1993;p. 157–184
  8. Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, et al Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2007;46(2):187–193
  9. Levine AJ, Hinkin CH, Castellon SA, Mason KI, Lam MN, Perkins A, et al Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS and Behavior. 2005;9(3):355–362
  10. Lindegren ML, Byers RH, Thomas P, Davis SF, Caldwell B, Rogers M, et al Trends in perinatal transmission of HIV/AIDS in the United States. Journal of the American Medical Association. 1999;282(6):531–538
  11. Liu H, Miller LG, Hays RD, Golin CE, Wu T, Wenger NS, et al. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. Journal of Acquired Immune Deficiency Syndromes. 2006;41(3):315–322
  12. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases. 2002;34(8):1115–1121
  13. Marhefka SL, Farley JJ, Rodrigue JR, Sandrik LL, Sleasman JW, Tepper VJ. Clinical assessment of medication adherence among HIV-infected children: Examination of the Treatment Interview Protocol (TIP). AIDS Care. 2004;16(3):323–338
  14. Marhefka SL, Koenig LJ, Allison S, Bachanas P, Bulterys M, Bettica L, et al Family experiences with pediatric antiretroviral therapy: Responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care and STDS. 2008;22(8):637–647
  15. Martin S, Elliott-Desorbo DK, Wolters PL, Toledo-Tamula MA, Roby G, Zeichner S, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatric Infectious Diseases Journal. 2007;26(1):61–67
  16. Pediatric AIDS Clinical Trials Group. (2001). Pediatric adherence questionnaire, modules 1 & 2. Retrieved from https://www.fstrf.org/qol/pactg/peds_ql.html
  17. Podsadecki, T.J., Vrijens, B.C., & Tousset, E.P. (2006, February). White coat compliance patterns make therapeutic drug monitoring (TDM) a potentially unreliable tool for assessing long-term drug exposure. Presented at the 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO.
  18. Reddington C, Cohen J, Baldillo A, Toye M, Smith D, Kneut C, et al Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatric Infectious Diseases Journal. 2000;19(12):1148–1153
  19. Simonds RJ, Steketee R, Nesheim S, Matheson P, Palumbo P, Alger L, et al Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies. AIDS. 1998;12(3):301–308
  20. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior. 2006;10(3):227–245
  21. Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007;119(6):e1371–e1383
  22. Steele RG, Anderson B, Rindel B, Dreyer ML, Perrin K, Christensen R, et al Adherence to antiretroviral therapy among HIV-positive children: Examination of the role of caregiver health beliefs. AIDS Care. 2001;13(5):617–629
  23. Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, et al Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109(4):e61
  24. Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois PA, et al Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006;118(6):e1745–e1757

 Dr. Allison is now at the National Institute of Mental Health. Dr. Marhefka is now at the University of South Florida College of Public Health. Dr. Carter is now at the International Center for AIDS Care and Treatment Programs at Columbia University. Dr. Bulterys is now with the CDC Global AIDS Program. Dr. Bachanas is now with the CDC Global AIDS Program, Atlanta, GA.

 The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

PII: S1055-3290(10)00041-5

doi: 10.1016/j.jana.2010.02.006

Journal of the Association of Nurses in AIDS Care
Volume 21, Issue 6 , Pages 478-488 , November 2010

Article Tools